Literature DB >> 21131639

Association between licence status and medication errors.

Sharon Conroy1.   

Abstract

BACKGROUND AND AIMS: Unlicensed and off label drug use in children is common and leads to well-recognised problems. This study aimed to determine whether a relationship exists between medication errors and licence status.
METHODS: Reports of errors in a UK children's hospital from 2004 to 2006 were analysed in terms of licence status and degree of harm and compared to the incidence of unlicensed and off label drug use in the hospital.
RESULTS: 20 of 158 (13%) errors were considered to have caused moderate harm and 12 of these involved unlicensed/off label drugs. 138 (87%) caused no or low harm. None caused severe harm. Unlicensed drug usage was significantly more likely to be associated with errors than licensed use in both children and neonates.
CONCLUSION: Unlicensed drug use appears to be associated with medication errors in neonates and children. Medication errors causing moderate harm were significantly more likely to be associated with both unlicensed and off label than licensed drugs.

Entities:  

Mesh:

Year:  2010        PMID: 21131639     DOI: 10.1136/adc.2010.191940

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  28 in total

Review 1.  Pharmacotherapy for Seizures in Neonates with Hypoxic Ischemic Encephalopathy.

Authors:  Elissa Yozawitz; Arthur Stacey; Ronit M Pressler
Journal:  Paediatr Drugs       Date:  2017-12       Impact factor: 3.022

2.  Off-label and unlicensed drug treatments in Neonatal Intensive Care Units: an Italian multicentre study.

Authors:  Laura Cuzzolin; Rocco Agostino
Journal:  Eur J Clin Pharmacol       Date:  2016-01       Impact factor: 2.953

3.  Patterns of Off-Label Prescribing in the Pediatric Intensive Care Unit and Prioritizing Future Research.

Authors:  Angela S Czaja; Pamela D Reiter; M Lynn Schultz; Robert J Valuck
Journal:  J Pediatr Pharmacol Ther       Date:  2015 May-Jun

Review 4.  Preventing medication errors in neonatology: Is it a dream?

Authors:  Roberto Antonucci; Annalisa Porcella
Journal:  World J Clin Pediatr       Date:  2014-08-08

5.  Inappropriate crushing information on ward lists: cytotoxic drugs, capsules, and modified release formulations are gravely neglected.

Authors:  Kristina Lohmann; Julia Ferber; Alexander Francesco Josef Send; Walter Emil Haefeli; Hanna Marita Seidling
Journal:  Eur J Clin Pharmacol       Date:  2014-01-28       Impact factor: 2.953

6.  Drug utilisation pattern and off-label use of medicines in Estonian neonatal units.

Authors:  Jana Lass; Ruth Käär; Kaarin Jõgi; Heili Varendi; Tuuli Metsvaht; Irja Lutsar
Journal:  Eur J Clin Pharmacol       Date:  2011-06-11       Impact factor: 2.953

Review 7.  Ethics of drug research in the pediatric intensive care unit.

Authors:  Niina Kleiber; Krista Tromp; Miriam G Mooij; Suzanne van de Vathorst; Dick Tibboel; Saskia N de Wildt
Journal:  Paediatr Drugs       Date:  2015-02       Impact factor: 3.022

Review 8.  How to optimize the evaluation and use of antibiotics in neonates.

Authors:  Evelyne Jacqz-Aigrain; Florentia Kaguelidou; John N van den Anker
Journal:  Pediatr Clin North Am       Date:  2012-09-01       Impact factor: 3.278

9.  Medication safety in neonatal care: a review of medication errors among neonates.

Authors:  Natalia Krzyzaniak; Beata Bajorek
Journal:  Ther Adv Drug Saf       Date:  2016-04-01

Review 10.  Interventions to reduce medication errors in neonatal care: a systematic review.

Authors:  Minh-Nha Rhylie Nguyen; Cassandra Mosel; Luke E Grzeskowiak
Journal:  Ther Adv Drug Saf       Date:  2017-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.